Alumis (ALMS) Income towards Parent Company (2023 - 2025)
Alumis' (ALMS) quarterly Income towards Parent Company came in at -$92.9 million in Q4 2025, down 181.75% year-on-year from $113.6 million in Q4 2024, and up 16.13% on a QoQ basis from -$110.8 million in Q3 2025.
Alumis (ALMS) Income towards Parent Company (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Income towards Parent Company data on file, last reported at -$92.9 million in Q4 2025.
- On a quarterly basis, Income towards Parent Company fell 181.75% year-over-year to -$92.9 million in Q4 2025; TTM through Dec 2025 was -$250.9 million, a 8.38% decrease from a year earlier, with the FY2025 full-year figure at -$243.3 million, down 4.66% from the prior year.
- Income towards Parent Company for Q4 2025 stood at -$92.9 million, up from -$110.8 million in the prior quarter.
- Over the last five years, Income towards Parent Company for ALMS reached as high as $59.3 million in Q2 2025 and fell as low as -$110.8 million in Q3 2025.
- Historically, Income towards Parent Company has averaged -$55.0 million across 3 years, with a median of -$48.9 million in 2024.
- On a YoY basis, Income towards Parent Company climbed as much as 204.98% in 2025 and fell as far as 181.75% in 2025.
- Year by year, Income towards Parent Company stood at -$41.3 million in 2023, then increased by 20.16% to -$33.0 million in 2024, then sank by 181.75% to -$92.9 million in 2025.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$92.9 million in Q4 2025, -$110.8 million in Q3 2025, and $59.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -92.89 Mn |
| Sep 30, 2025 | -110.75 Mn |
| Jun 30, 2025 | 59.32 Mn |
| Mar 31, 2025 | -106.62 Mn |
| Dec 31, 2024 | -32.97 Mn |
| Sep 30, 2024 | -93.12 Mn |
| Jun 30, 2024 | -56.51 Mn |
| Mar 31, 2024 | -48.94 Mn |
| Dec 31, 2023 | -41.30 Mn |
| Sep 30, 2023 | -44.56 Mn |
| Jun 30, 2023 | -36.71 Mn |